Novel bone-targeted Src tyrosine kinase inhibitors prevent bone loss and stimulate osteoblast activity.

被引:0
|
作者
Boyce, B
Xing, L
Bain, S
Shen, V
Liu, C
Chen, H
Wang, Y
Shakespeare, W
Metcalf, C
Sundaramoorthi, R
Keenan, T
Bohacek, R
van Schravendijk, MR
Dalgarno, D
Iuliucci, J
Weigele, M
Sawyer, T
机构
[1] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[2] SkeleTech, Bothell, WA USA
[3] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S148 / S148
页数:1
相关论文
共 50 条
  • [31] THE PDGFR/SRC SIGNALING PATHWAY-TARGETED THERAPY WITH NOVEL TUSC2-NANOPARTICLES AND TYROSINE KINASE INHIBITORS FOR HUMAN LUNG CANCER
    Wu, Quanglin
    Liu, Qing
    Sakai, Ryo
    Hangauer, David
    Roth, Jack
    Ji, Lin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S459 - S459
  • [32] C-src tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis
    Myoui, A
    Nishimura, R
    Williams, PJ
    Hiraga, T
    Tamura, D
    Michigami, T
    Mundy, GR
    Yoneda, T
    CANCER RESEARCH, 2003, 63 (16) : 5028 - 5033
  • [33] Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance
    Siu, Man Kit
    Abou-Kheir, Wassim
    Yin, Juan Juan
    Chang, Yung-Sheng
    Barrett, Ben
    Suau, Florent
    Casey, Orla
    Chen, Wei-Yu
    Fang, Lei
    Hynes, Paul
    Hsieh, Yao-Yu
    Liu, Yen-Nien
    Huang, Jiaoti
    Kelly, Kathleen
    ONCOTARGET, 2014, 5 (11) : 3770 - 3784
  • [34] Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?
    Normanno, N
    Gullick, WJ
    ENDOCRINE-RELATED CANCER, 2006, 13 (01) : 3 - 6
  • [35] Discovery of novel dual action Src kinase inhibitors demonstrating anti-resorptive and bone formation activities in vitro and in vivo.
    Xing, L
    Wang, Y
    Sundaramoorthi, R
    Keenan, T
    Metcalf, C
    Shakespeare, W
    Bohacek, R
    van Schravendijk, MR
    Yamashita, T
    Sheu, T
    Puzas, E
    Dalgarno, D
    Iuliucci, J
    Sawyer, T
    Boyce, BF
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S377 - S377
  • [36] A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo
    Missbach, M
    Jeschke, M
    Feyen, J
    Müller, K
    Glatt, M
    Green, J
    Susa, M
    BONE, 1999, 24 (05) : 437 - 449
  • [37] Structure-activity relationship (SAR) and in vivo activity of a novel series of C5-substituted anilinoquinazolines with highly potent and selective inhibition of c-Src tyrosine kinase activity.
    Hennequin, LF
    Van der Brempt, CL
    Morgentin, R
    Olivier, A
    Plé, PA
    Allen, J
    Costello, GF
    Curwen, J
    Fennell, M
    Green, TP
    Jacobs, V
    Whittaker, R
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6183S - 6184S
  • [38] A Naturally Occurring SRC-1 Variant Correlates with Clinical Bone Loss, and Increased Osteoclast Activity in a Novel Mouse Model
    Watters, Rebecca J.
    Hartmaier, Ryan J.
    Lee, Adrian V.
    Verdelis, Kostantinos
    Lee, Brendan
    Chen, Yuqing
    O'Malley, Bert W.
    Xu, Jianming
    Jiang, Shiming
    Brufsky, Adam
    Galson, Deborah
    Oesterreich, Steffi
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [39] Small molecule inhibitors of IκB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo
    Idris, Aymen I.
    Krishnan, Maala
    Simic, Petra
    Landao-Bassonga, Euphemie
    Mollat, Patrick
    Vukicevic, Slobodan
    Ralston, Stuart H.
    FASEB JOURNAL, 2010, 24 (11): : 4545 - 4555
  • [40] THE PROLIFERATIVE ACTIVITY OF THE BONE MARROW CELLS INVESTIGATED IN VITRO CELL CULTURE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS
    Perekhrestenko, T.
    Sviezhentseva, I.
    Bilko, D.
    Tretiiak, N.
    Dyagil, I.
    HAEMATOLOGICA, 2016, 101 : 451 - 452